Combo approach to treat COVID?

  • We are currently looking at effects of a single drug in clinical trials. Could it be possible that a combination of 3 or more as in HIV, could be the key to treat covid-19?

    There is clinical trial data emerging using bi or tri therapy. Indeed attacking the virus on multiple fronts might be advantageous. as the data accumulates our tools will use itA recent trial in Hong Kong showed that interferon+lopinavir+ritonavir+ribavirin was better than lopinavir+ritonavir alone. Yes, we think that polypharmacy is likely to be more effective. But, DDIs and synergistic safety issues call for caution.

  • You must be logged in to reply to this topic.